Skip to main content
. 2020 May 27;10:831. doi: 10.3389/fonc.2020.00831

Table 5.

Novel potential biomarkers for PanNENs diagnosis, prognosis and treatment monitoring.

Putative markers Source Level Clinical use References
Potentially Prognostic and/or Predictive Delta-like protein 3 DLL-3 Surgical/endoscopic biopsy Over-expressed Potentially prognostic and therapeutic target (236, 237)
Tumor-Associated—Macrophages TAMs Surgical/endoscopic biopsy Increased Associated to reduced DSS (61)
G protein coupled receptor-associated sorting protein 1 GPRASP-1 Serum Down-regulated Neuroendocrine de-differentiation (235)
Glucose transporter 1 GLUT-1 Surgical/endoscopic biopsy Over-expressed Prognostic for higher metabolism and tumor aggressiveness (90)

PanNENs, Pancreatic Neuroendocrine Neoplasia; GEP-NENs, Gastro-Entero-Pancreatic Neoplasia.